Skip to main content

N 739 150 Pill - tan orange capsule/oblong, 18mm

Pill with imprint N 739 150 is Tan / Orange, Capsule/Oblong and has been identified as Mexiletine Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.

Mexiletine is used in the treatment of Ventricular Tachycardia; Arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N 739 150

Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150 Front
Mexiletine hydrochloride 150 mg N 739 150 Back

Mexiletine Hydrochloride

Imprint
N 739 150
Strength
150 mg
Color
Tan / Orange
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
silicon dioxide, magnesium stearate, corn starch, FD&C Yellow No. 6, gelatin, titanium dioxide, D&C Red No. 28, FD&C Blue No. 1, ammonia, ferrosoferric oxide, D&C Yellow No. 10, alcohol, FD&C Blue No. 2, FD&C Red No. 40, isopropyl alcohol, butyl alcohol, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-8739 Teva Pharmaceuticals USA, Inc.
42291-0624 AvKare, Inc.
49999-0916 (Discontinued) Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.